Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00387062 · ClinicalTrials.gov registry record · Phase 1
Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment
A Phase 1 study, sponsored by Posit Science Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT00387062 is a Phase 1 study that has completed, run by Posit Science Corporation. The registered enrollment target is 50 participants.
The verdict
NCT00387062, a Phase 1 study, has completed, sponsored by Posit Science Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The investigators hypothesize that continuous active interaction with environments that are demanding to sensory, cognitive, and motor systems, together with imbedded rewards for successful performance, will help improve memory and cognitive functioning in patients suffering from "chemobrain".
Interventions
- DEVICE Computer-based Cognitive Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-10 |
| Est. Completion | 2008-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00387062
The ClinicalTrials.gov registry entry for NCT00387062 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Posit Science Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Computer-based Cognitive Training is the first listed.
NCT00387062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00387062 about?
NCT00387062 is a clinical study titled "Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment". The investigators hypothesize that continuous active interaction with environments that are demanding to sensory, cognitive, and motor systems, together with imbedded rewards for successful performance, will help improve memory and cognitive functioning in patients suffering from "chemobrain".
What is the current status of trial NCT00387062?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2006-10. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00387062?
The interventions under investigation include: Computer-based Cognitive Training (DEVICE).
Who is sponsoring clinical trial NCT00387062?
This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.